Phase 1 Clinical Trial of intra-thoracic administration of Zoredronic Acid in Subjects with Unresectable Malignant Pleural Mesothelioma

Trial Profile

Phase 1 Clinical Trial of intra-thoracic administration of Zoredronic Acid in Subjects with Unresectable Malignant Pleural Mesothelioma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Mesothelioma
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Dec 2015 Planned End Date changed from 26 Feb 2015 to 31 Mar 2019, as reported by University Hospital Medical Information Network - Japan.
    • 04 Dec 2014 Planned End Date changed from 1 Jan 2015 to 26 Feb 2015 as reported by University Hospital Medical Information Network - Japan.
    • 04 Dec 2013 Planned end date 1 Jan 2015 added as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top